Found 6 matching trials
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
PHASE1This phase I clinical trial evaluates the safety and feasibility of adminis...
Location
UCLA / Jonsson Comprehensive Cancer Center
Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer
PHASE1The primary objective of this phase 1 trial is to determine the dose-depend...
Location
Henry Ford Health System
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
PHASE1The purpose of this study is to determine whether \[18F\]FHBG is suitable f...
Location
University of California Los Angeles
TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
PHASE1This phase I trial studies the side effects of NY-ESO-1 TCR engineered peri...
Location
UCLA / Jonsson Comprehensive Cancer Center
GEN2 Directed Cancer Immunotherapy Trial
PHASE1Phase 1, non-randomized, open label dose escalation clinical trial evaluati...
Location
Makati Medical Center
Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer
PHASE1This phase 1 trial will investigate the toxicity of combining interleukin 1...
Location
Henry Ford Hospital